Related Experiment Video
Updated: Mar 26, 2026

11:42
Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells
Published on: April 7, 2017
9.9K
Molecular Pathology of Sarcoma.
1Department of Pathology, University of Virginia Health System, 1215 Lee Street, HEP 3064, Charlottesville, VA 22908, USA.
Surgical Pathology Clinics
|February 4, 2016
Summary
Molecular pathology advances are transforming soft tissue tumor diagnosis for surgical pathologists. This guide offers practical, morphology-based insights with clinically relevant molecular findings for better patient care.
Area of Science:
- Pathology
- Oncology
- Genetics
Background:
- Tissue-based molecular pathology is rapidly evolving.
- This evolution significantly impacts the diagnostic workflow for soft tissue tumors.
- Surgical pathologists require updated, practical guidance.
Purpose of the Study:
- To provide a practical overview of molecular pathology in soft tissue tumor diagnosis.
- To focus on clinically validated findings with diagnostic or therapeutic relevance.
- To integrate morphological approaches with molecular data.
Main Methods:
- Morphologically based analysis of soft tissue tumors.
- Focus on differential diagnoses and relevant clinical scenarios.
- Incorporation of molecular techniques as ancillary tools.
Main Results:
- Clinically validated molecular findings are crucial for accurate diagnosis.
- Differential diagnoses are best addressed through integrated morphological and molecular assessments.
- Molecular techniques serve as invaluable adjuncts to traditional pathology.
Conclusions:
- Molecular pathology is integral to modern soft tissue tumor practice.
- A morphology-first approach, augmented by molecular data, enhances diagnostic accuracy.
- Understanding molecular alterations aids therapeutic decisions and improves patient outcomes.
Related Concept Videos
Tumor Progression
7.8K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.8K
Tumor Progression
3.5K
3.5K
Rous Sarcoma Virus (RSV) and Cancer
5.9K
5.9K
Rous Sarcoma Virus (RSV) and Cancer
6.6K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
6.6K
mTOR Signaling and Cancer Progression
5.1K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
5.1K
mTOR Signaling and Cancer Progression
1.7K
1.7K

